Divyen H. Patel, Ph.D., Founder/President
Dr. Patel has focused his entire scientific career in trying to find novel and innovative ways to improve the outcome in cancer patients. He completed his Ph.D. at the University of Leeds in England, publishing 14 publications as a graduate student, focusing on establishing definitive methods for diagnosis of myeloid leukemia. He joined the University of Tennessee in 1992 to study signal transduction to get a better understanding of the causative agents of various disease states.